{
    "nct_id": "NCT06233877",
    "official_title": "An Open Label Phase 2 Trial to Evaluate the Safety, Tolerability, and Efficacy of Low Dose G-FLIP in Combination With Mitomycin C in Patients With Stage IV Pancreatic Cancer Who Have Failed First-Line Treatment",
    "inclusion_criteria": "* Histologically confirmed metastatic (Stage IV) pancreatic adenocarcinoma.\n\n  * Failed first-line chemotherapy.\n  * ECOG performance status of 0-2.\n  * Expected survival of more than 3 months.\n  * Adequate organ function as indicated by lab values.\n  * Age 18 or older.\n  * Signed informed consent.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* â€¢ Known brain metastases.\n\n  * Significant cardiovascular or other uncontrolled diseases.\n  * Pregnant or breastfeeding women",
    "miscellaneous_criteria": ""
}